Feature Resource: WHO COVID-19 Vaccine Introduction Toolbox

Check out the COVID-19 vaccine introduction toolbox, designed by the World Health Organization (WHO) to equip all countries to prepare for and implement COVID-19 vaccination by providing guidance, tools and training. This toolbox – intended to support Ministries of Health, health workers, partner organizations, and other stakeholders – is organized in line with the Guidance on Developing a National Deployment and Vaccination Plan for COVID-19 vaccines and will be updated as new resources become available. 

The toolkit is now available in all UN languages: Arabic, Chinese, French, Russian and Spanish.

Stand out resources of the toolbox include: 

• Monitoring COVID-19 Vaccination guidance for data collection, key performance indicators and the use of information systems

• The WHO Coronavirus Dashboard to track global vaccine roll-out

• A COVID-19 vaccine-specific resources course on OpenWHO

• Information about the COVAX No-Fault Compensation (NFC) Program for AMC Eligible Economies

• A COVID-19 vaccine checklist for frontline health workers

Other focus areas in the toolbox include:

• Developing a National Deployment and Vaccination Plan (NDVP)

• Submitting a National Deployment and Vaccination Plan (NSVP)

• Regulatory preparedness

• Indemnification and liability

• Costing and funding

COVID-19 Vaccine Specific Resources

• The OpenWHO COVID-19 vaccine-specific resources course is now available in EN CH RU

You can also watch the videos from the COVID-19 vaccine-specific resources course on how to handle, prepare, and administer COVID-19 vaccines here:

• AstraZeneca ChAdOx1-S/nCoV-19 [recombinant] COVID-19 vaccine training video (5 min)
• Moderna mRNA-1273 COVID-19 vaccine training video (6 min)
• Pfizer Comirnaty Tozinameran training video (7 min)
• Recognizing Anaphylaxis training video (4 min)

• The Janssen (Johnson and Johnson) vaccine explainer is now available. 

• Considerations for optimizing deployment of AstraZeneca/AZD1222 and SII/Covishield vaccines in a time-limited constrained supply situation provides an overview of programmatic considerations to guide national decision-making.

COVID-19 Vaccine Effectiveness Guidance

• Vaccine effectiveness and impact guidance and its accompanying sample size calculator provide interim guidance on how to assess COVID-19 vaccine effectiveness. It discusses critical considerations in the design, analysis and interpretation of vaccine effectiveness evaluations to avoid biased results.

COVID-19 Vaccination Capacity Training Resources

• The Health Worker COVID-19 Vaccination course is now available in various languages: AR CH EN FR RU SP  and also in Dutch, Indonesian, Macedonian, and Vietnamese. If you’d like to request access to the presentations, please email [email protected]
• The COVID-19 immunization checklist, an important job aid for health workers, is also available in new language versions. AR EN FR RU SP PT
• The COVID-19 Vaccination: Building Global Capacity webinars continue every Tuesday from 12:00 to 13:00 CET (interpretation into French and Spanish). Webinar materials are available through TechNet-21. For registration links and additional resources, please visit the Project ECHO website.

Check out what's new!

Vaccines Explained and NEW Animations

• The effects of virus variants on COVID-19 vaccines EN NEW: ES FR ZH
• Safety of COVID-19 Vaccines: EN NEW: ES ZH
• Getting the COVID-19 Vaccine: EN NEW: ES
• Q&A: What is the ACT-Accelerator? EN NEW: FR ZH
• NEW Break the chain of COVID-19 transmission Hindi
• NEW Checkmate COVID-19 EN 
• NEW How different COVID-19 tests work EN

Courses and Technical Guidance

• NEW: Clinical management of patients with COVID-19: Initial approach to the acutely ill patient
• Establishment of a COVID-19 mRNA vaccine technology transfer hub to scale up global manufacturing NEW: EN
• COVID-19 and mandatory vaccination: Ethical considerations and caveats NEW: EN
• Evaluation of COVID-19 vaccine effectiveness EN NEW: FR RU
• Priority medical devices list for the COVID-19 response and associated technical specifications EN NEW: AR FR RU ZH 

For questions, comments or feedback, please email [email protected].

*Last updated May 7, 2021